ArticleBlood advances2026

TNFRSF17 genomic profiling guides retreatment with alternative BCMA-directed immunotherapies in multiple myeloma.

Benjamin Podvin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.